Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Multhoff

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Molecular Therapy Oncolytics|December 2, 2022
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastomaRebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, et al.
Radiation Oncology (London, England)|June 11, 2014
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckMathias Gehrmann, Hanno M Specht, Christine Bayer, et al.
Frontiers in Molecular Biosciences|June 3, 2021
Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma PatientsDominik Lobinger, Jens Gempt, Wolfgang Sievert, et al.
Biomedicines|December 23, 2023
Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 GliomaPhilipp Lennartz, Dennis Thölke, Ali Bashiri Dezfouli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2021
Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagusHsin-Yu Fang, Stefan Stangl, Sabrina Marcazzan, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 27, 2026
Multiphysics-Driven Assembly of Biomimetic VesiclesTimofei Solodko, Ian Gimino, Aastha Chandiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
<i>CXCR4</i> Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal AdenocarcinomaHsin-Yu Fang, Natasha Stephens Münch, Margret Schottelius, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
British Journal of Cancer|October 15, 2024
Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cellsKatharina L K Holzmann, Johanna L Wolf, Stefan Stangl, et al.
Biomedicines|August 26, 2023
Hsp70-A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced CancersAlexia Xanthopoulos, Ann-Kathrin Samt, Christiane Guder, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Molecular Therapy Oncolytics|December 2, 2022
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastomaRebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, et al.
Radiation Oncology (London, England)|June 11, 2014
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckMathias Gehrmann, Hanno M Specht, Christine Bayer, et al.
Frontiers in Molecular Biosciences|June 3, 2021
Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma PatientsDominik Lobinger, Jens Gempt, Wolfgang Sievert, et al.
Biomedicines|December 23, 2023
Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 GliomaPhilipp Lennartz, Dennis Thölke, Ali Bashiri Dezfouli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2021
Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagusHsin-Yu Fang, Stefan Stangl, Sabrina Marcazzan, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 27, 2026
Multiphysics-Driven Assembly of Biomimetic VesiclesTimofei Solodko, Ian Gimino, Aastha Chandiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
<i>CXCR4</i> Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal AdenocarcinomaHsin-Yu Fang, Natasha Stephens Münch, Margret Schottelius, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
British Journal of Cancer|October 15, 2024
Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cellsKatharina L K Holzmann, Johanna L Wolf, Stefan Stangl, et al.
Biomedicines|August 26, 2023
Hsp70-A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced CancersAlexia Xanthopoulos, Ann-Kathrin Samt, Christiane Guder, et al.
Pageof 24